Refine by
Upper Limbs Articles & Analysis
18 news found
– a Japanese pharmaceutical company with expertise in DMD and orphan diseases The Lancet published positive results from our Phase 2, HOPE-2 trial evaluating CAP-1002 in late-stage Duchenne muscular dystrophy (Publication Link Here) Publication highlighted one-year final data for safety and efficacy in slowing upper limb and cardiac function ...
Many patients with stroke experience persistent upper limb (UL) impairments. This single-blind, randomized, controlled trial[i] explored the impact of partially substituting conventional therapy (CT) with RAT on the three International Classification of Functioning, Disability and Health (ICF) domains. ...
ByAxinesis
Axinesis expands its intensive functional rehabilitation offer We are delighted to announce the launch of our new REAtouch® Lite: the device for decentralized upper-limb rehabilitation in the rehabilitation centre or at home. REAtouch Lite is the portable version of the REAtouch: our device for intensive bimanual functional ...
ByAxinesis
One-Year Final Data Highlights Lead Cell Therapy Asset, CAP-1002, for Safety and Efficacy in Slowing Upper Limb and Cardiac Function Deterioration in Patients Data Sets Stage for Pivotal Phase 3 HOPE-3 Clinical Trial Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics ...
Across the study population, the treatment reduced the rate at which upper limb function declined and also improved cardiac function. It is important to understand the real differences this treatment can potentially make in patients’ lives. ...
BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
AXINESIS entrusts DESSINTEY with the distribution of its REAplan robot in France With this collaboration, Dessintey proposes a unified offer IVS3 + REAplan® for a complete and intensive upper limb rehabilitation. The upper limb, essential for daily life activities ...
ByAxinesis
Each year in the US, 50-60% of the 658,000 stroke survivors have upper extremity motor deficits that persist for many months to years after their stroke. ...
Using a patent-protected groundbreaking Error Enhancement technology, BioXtreme has developed a robotic system that helps with upper limb motoric rehabilitation. Our product, deXtreme preforms automatic rebuild of motion range and capability through adaptive/intuitive learning. ...
The CE Marking is intended for deXtreme, our upper limb neurorehabiliatation robotic device, meant to treat stroke and other TBI patients with our novel Error Enhancement technology. ...
Using a patent-protected groundbreaking Error Enhancement technology, BioXtreme has developed a robotic system that helps with upper limb motoric rehabilitation. Our product, deXtreme™ preforms automatic rebuild of motion range and capability through adaptive/intuitive learning. ...
Using a patent-protected groundbreaking Error Enhancement technology, BioXtreme has developed a robotic system that helps with upper limb motoric rehabilitation. Our product, deXtreme preforms automatic rebuild of motion range and capability through adaptive/intuitive learning. ...
In total the study recruited 16 young adults (average age 27 years) with traumatic, early (less than 18 months post injury) spinal cord injury to the neck (C5-C7), who were referred to Austin Health in Melbourne for restoration of function in the upper limb. Most were the result of motor vehicle accidents or sports injuries. Participants underwent single or ...
The manuscript, titled "Safety, Feasibility and Efficacy of Vagus Nerve Stimulation (VNS) Paired with Arm Rehabilitation Following Ischemic Stroke" reports clinical results from a paired VNS therapy for stroke patients with significantly reduced upper limb mobility. This condition can incapacitate the patient and impede the ability to perform daily tasks required ...